Funding for this research was provided by:
Natural Science Foundation of Zhejiang Province (LY19H080007)
Article History
Received: 16 February 2024
Accepted: 1 July 2024
First Online: 18 July 2024
Declarations
:
: The study was conducted in accordance with The animal use protocol approved by the Institutional Animal Care and Use Committee (IACUC), Zhejiang Center of Laboratory Animals(ZJCLA). (“Mesenchymal Stem Cell-Based Gene Therapy for Hemophilia B using scAAV-DJ/8-LP1-hFIXco Transduction” Approval No. ZJCLA-IACUC-20020133, approved September 15th, 2020 ). The use of a hemophilia B patient serum sample was approved by institutional ethnic review board of Children’s Hospital under approval number 2015-IRB-Q.5. Written informed consent for the utilization of the sample was obtained from the patient’s guardian.
: Not applicable.
: The authors declare that they have no competing interests.